Cassandra Burt-Ernst, PA
Physician Assistant · Jacksonville, FLNPI 1285767103
Payments from drug & device makers
Across 280 payments — averaging $24.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dexcom, Inc.$1K
- Novo Nordisk$729
- Abbott$705
- Amgen$500
- Bayer$394
- Boehringer Ingelheim$385
- plus $3K from 28 others
What the payments were for
- Food & beverage$6,792100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dexcom, Inc. | 44 | $1,020 |
| Novo Nordisk | 32 | $729 |
| Abbott | 33 | $705 |
| Amgen(2 entities) | 25 | $500 |
| Bayer | 15 | $394 |
| Boehringer Ingelheim | 15 | $385 |
| Medtronic | 15 | $360 |
| Lilly USA, LLC | 12 | $334 |
| Mannkind Corporation | 9 | $323 |
| AstraZeneca(2 entities) | 13 | $237 |
| Amneal Pharmaceuticals LLC | 13 | $232 |
| Radius Health, Inc. | 8 | $221 |
| Tandem Diabetes Care, Inc. | 6 | $204 |
| Insulet Corporation | 3 | $197 |
| Sequel Med Tech, LLC | 3 | $165 |
| Ascendis Pharma Endocrinology Inc | 2 | $152 |
| Sanofi-aventis U.S. LLC | 6 | $120 |
| Xeris Pharmaceuticals, Inc. | 4 | $81 |
| Astellas Pharma US Inc | 4 | $68 |
| Cequr Corporation | 1 | $37 |
| Merck | 2 | $34 |
| Rhythm Pharmaceuticals, Inc. | 1 | $30 |
| BETA Bionics, Inc. | 1 | $30 |
| GRT US Holding, Inc. | 1 | $29 |
| AbbVie | 2 | $28 |
| Lifescan, Inc. | 2 | $27 |
| Boston Scientific | 1 | $25 |
| Corcept Therapeutics | 1 | $24 |
| Azurity Pharmaceuticals, Inc. | 1 | $23 |
| Acella Pharmaceuticals, LLC | 1 | $22 |
| Amarin Pharma, Inc. | 1 | $17 |
| IBSA Pharma Inc. | 1 | $15 |
| Acerus Pharmaceuticals Corporation | 1 | $14 |
| Endo Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,792 in reported general payments places this provider in the 90th percentile of 8,062 physician assistant providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 98 | $140,028 |
| JardianceEmpagliflozin | 54 | $58,331 |
| Humulin R U-500Insulin Regular, Human | 22 | $40,513 |
| TrulicityDulaglutide | 28 | $31,311 |
| FarxigaDapagliflozin Propanediol | 25 | $29,642 |
| JanuviaSitagliptin Phosphate | 21 | $26,616 |
| Tresiba Flextouch U-100Insulin Degludec | 31 | $23,792 |
| Tresiba Flextouch U-200Insulin Degludec | 26 | $19,403 |
| Novolog FlexpenInsulin Aspart | 43 | $15,008 |
| MounjaroTirzepatide | 11 | $13,462 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 77 | $11,252 |
| Humalog Kwikpen U-100Insulin Lispro | 13 | $4,467 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 23 | $3,654 |
| SynthroidLevothyroxine Sodium | 40 | $2,964 |
| Levothyroxine Sodium | 271 | $2,284 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $729 | $140,02898 claims |
| Boehringer IngelheimJardiance | $385 | $58,33154 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $334 | $44,77339 claims |
| AstraZenecaFarxiga | $237 | $29,64225 claims |
| MerckJanuvia | $34 | $26,61621 claims |
| AbbVieSynthroid | $28 | $2,96440 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $232 | $2,284271 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,062 physician assistant providers in Florida.
Other physician assistant in Jacksonville
- Elizabeth KeaneJacksonville$84K
- Layla McDanielJacksonville$74K
- Bonnie ApplerJacksonville$50K
- Todd WurtzJacksonville$31K
- Richard MarshallPort Orange$988K
- Audrey BeckerSt Augustine$689K
- Kevin WilliamsTampa$647K
- Brian BonomoLecanto$559K
- Melissa SingletonOcala$482K
- Reeli ReinuMaitland$427K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.